Drug Database
TJ

TJ-15 (OGT)

✓ Approved

Tsumura · 治疗药物

什么是 TJ-15?

TJ-15 是一种治疗药物,由Tsumura研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名OGT
公司Tsumura
给药途径Oral (PO)
状态Approved

治疗适应症

TJ-15 针对 5 个适应症,涉及 5 个治疗领域。

治疗领域疾病/病症分期
Skin and subcutaneous tissue disordersEczema✓ Approved
Gastrointestinal disordersGastritis✓ Approved
Vascular disordersHypertension✓ Approved
Psychiatric disordersObsessive-compulsive disorder✓ Approved
Nervous system disordersCerebral cyst haemorrhage✓ Approved

相关研究文献

PubMedPhysiological reports2026-11-19

Growth differentiation factor-15 is associated with soluble prorenin receptor in young females with increased adiposity: The African-PREDICT study.

Maugana Vuledzani Felicia VF, Mokgonyana Phuti Josephine PJ, Mels Catharina Martha Cornelia CMC, Uys Aletta Sophia AS et al.

Obesity in young adults is a global health concern, highlighting the need to investigate circulating biomarkers involved in its pathophysiology to potentially inform future therapeutic interventions. Growth differentiation factor-15 (GDF-15), a stress-responsive cytokine and the soluble prorenin receptor (s(P)RR), a component of the renin-angiotensin system (RAS), are linked to obesity, yet their interaction in young adults with varying adiposity status remains unclear. We aimed to (a) compare GDF-15 and s(P)RR concentrations by adiposity status and sex; and (b) explore associations between GDF-15 and s(P)RR according to adiposity and sex. This cross-sectional study included 1176 young adults aged 20-30 years, stratified by body mass index categories within each sex group (males: n = 567; females: n = 609). GDF-15 and s(P)RR concentrations were measured in serum. GDF-15 levels were higher in underweight males (p = 0.025) than in normal weight, overweight and obese males, whereas s(P)RR levels were higher in obese males (p < 0.001) and females (p = 0.002) than in their underweight, normal weight and overweight counterparts. In fully adjusted models, GDF-15 was positively associated with s(P)RR in overweight (β = 0.33; p = 0.001) and obese (β = 0.21; p = 0.027) females. Tissue RAS activation and cellular stress responses may occur early in young females with increased adiposity, highlighting that s(P)RR and GDF-15 may be potential therapeutic targets for obesity prevention and early intervention.

PMID 43053636
阅读全文 →
PubMedSignal transduction and targeted therapy2026-11-19

G protein-coupled receptor 15-guided CD8⁺ TIGR cells: a new strategy for suppressing inflammatory bowel disease.

Lee Hye-Su HS, Oh Hanseul H

PMID 43052237
阅读全文 →
PubMedWorld journal of diabetes2026-11-19

Correction to "Jianpi Gushen Huayu decoction ameliorated diabetic nephropathy through modulating metabolites in kidney, and inhibiting TLR4/NF-κB/NLRP3 and JNK/P38 pathways".

Lv Shu-Quan SQ

[This corrects the article DOI: 10.4239/wjd.v15.i3.502.][This corrects the article on p. 502 in vol. 15, PMID: 38591083.].

PMID 43053761
阅读全文 →
PubMedBMC oral health2026-11-19

Effects on patients postoperative morbidity and donor site wound healing of A-PRF and CGF application after free gingival graft harvesting: a comparative randomized clinical trial.

Öngöz Dede Figen F, Gökmenoğlu Ceren C, Çelen Kübra K, Dede Doğu Ömür DÖ et al.

The objective of this study was to compare and evaluate the effects of concentrated growth factor (CGF) and advanced platelet-rich fibrin (A-PRF) clot membranes on palatal epithelial wound healing and postoperative discomfort following free gingival graft (FGG) harvesting. Forty-five patients who underwent FGG harvesting were randomly allocated into three groups: (1) control group (n = 15), receiving only a sterile gelatin sponge; (2) A-PRF group (n = 15), receiving A-PRF clot membranes; and (3) CGF group (n = 15), receiving CGF clot membranes at the donor site. The epithelization rate, color match, and sensation scores of the palatal wound were assessed at 1, 2, 3, and 4 weeks postoperatively. Pain levels, analgesic consumption, and bleeding time were self-reported by patients for the first 7 days of healing. No significant differences in epithelialization and sensitivity scores were observed among the groups at any time point (P>.05). Palatal color matching was superior in the A-PRF and CGF groups compared to the control group at 1 and 2 weeks (P<.05). Visual analog scale (VAS) pain scores and the number of analgesic tablets consumed were lower in the CGF group than in the control group on days 2, 3, 4, and 5 (P<.05). At 14 days, VAS pain scores were significantly lower in both the A-PRF and CGF groups compared to the control group (P<.05). Immediate bleeding time at the donor site was significantly reduced in the A-PRF and CGF groups compared to the control group (P<.05), while no significant differences were found among the groups regarding late bleeding at 7 days postoperatively (P>.05). Although CGF demonstrated a slight advantage over A-PRF membranes, the findings indicate that neither CGF nor A-PRF accelerates epithelialization or palatal wound healing. However, the benefits of A-PRF and CGF appear to be mainly limited to postoperative comfort and immediate hemostasis rather than acceleration of epithelialization or sensory recovery. Application of A-PRF and CGF may reduce immediate bleeding and postoperative pain following FGG harvesting. ClinicalTrials.gov NCT07439068, registered on 10 February 2026. (Retrospectively registered).

PMID 43052952
阅读全文 →
PubMedAJE advances : research in epidemiology2026-11-19

Can self- or caregiver-administered nasal spray influenza vaccination improve outcomes? An agent-based model using the framework for reconstructing epidemiological dynamics.

Williams Katherine V KV, Nowalk Mary Patricia MP, Krauland Mary G MG, Mandell Alexis J AJ et al.

Newly licensed self- or caregiver-administered nasal spray live attenuated influenza vaccine (LAIV), available to order for home delivery, may improve vaccination coverage (VC) among adults aged 18-49 overall, as well as among those in this age group who live in households with school-aged children. Using the agent-based Framework for Reproducing Epidemiological Dynamics, which simulates influenza transmission in US census-based populations with defined household structures, we modeled the impact of: (1) 5%-15% VC increase among those aged 18-49 through self-administration and (2) household-based strategies for ages 5-17 and 18-49 that may occur from home LAIV orders. The household strategies included vaccinating children aged 5-17, followed by their 18-49-year-old head of household (HH) (kids + HH), and vaccinating children aged 5-17 and all household adults aged 18-49 (kids + adults). A 5%-15% VC increase in adults aged 18-49 reduced symptomatic cases in all adults by up to 10%. Among household strategies, kids + adults yielded a higher VC increase (9.2%) and greater reduction in symptomatic cases (5.7%) among adults ≥18 than the kids + HH strategy. The convenience of self-administration and household-based LAIV strategies in homes with school-age children may enhance adult VC and reduce influenza burden.

PMID 43053808
阅读全文 →
PubMedEuropean heart journal. Valvular and structural heart disease2026-11-19

Changes in loop diuretic use following mitral valve surgery for mitral regurgitation according to age: a nationwide cohort study.

Melchior Simon E SE, Schöps Liv B LB, Petersen Jeppe K JK, Carranza Christian L CL et al.

Loop diuretic use (LDU) may provide complementary information on post-operative heart failure (HF) burden after mitral valve surgery (MVS). We investigated changes in LDU before and after MVS for mitral regurgitation (MR) and assessed post-operative HF admission according to age. Using Danish nationwide registries, we identified patients aged ≥18 years discharged after first-time MVS for MR between 1996 and 2022. LDU was assessed from redeemed prescriptions before surgery and at post-operative landmarks. HF admission within 5 years was estimated with death as a competing risk. Among 6840 patients, LDU was 46.2% before surgery and declined among survivors to 27.0% at 12-15 months and 23.7% at 36-39 months. Pre-operative use was more frequent with increasing age, ranging from 27.9% in patients aged 18-49 years to 64.3% in those aged ≥80 years. Postoperatively, LDU remained common, ranging from 13.5% to 41.6% at 12-15 months and from 11.9% to 35.4% at 36-39 months across age groups. The 5-year cumulative incidence of HF admission was 20.9% (95% CI: 20.0-22.0%) overall and increased across age groups, from 13.9% to 27.4%. Pre-operative LDU was associated with higher 5-year mortality irrespective of recorded HF status. LDU declined after MVS for MR but remained common, particularly among older patients, and showed an age-related pattern consistent with hospital admission for HF.

PMID 43053869
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多TJ-15